Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 11, Pages e2021818118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-03-09
DOI
10.1073/pnas.2021818118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
- (2020) David Schafflick et al. Nature Communications
- Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions
- (2020) Nina L Fransen et al. BRAIN
- Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
- (2019) Hans Lassmann Frontiers in Immunology
- Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis
- (2019) Atsushi Kadowaki et al. BRAIN
- Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation
- (2019) Chenyang Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells
- (2018) Joana Machado-Santos et al. BRAIN
- Variant of EOMES Associated with Increasing Risk in Chinese Patients with Relapsing-remitting Multiple Sclerosis
- (2018) Bao-Gou Xiao et al. CHINESE MEDICAL JOURNAL
- EOMES-positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriers
- (2018) Karine Chemin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
- (2018) Raju Kapoor et al. LANCET NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Tissue-resident memory T cells populate the human brain
- (2018) Joost Smolders et al. Nature Communications
- Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
- (2017) Burhan Z. Chaudhry et al. Neurotherapeutics
- Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
- (2017) Liesbet M. Peeters et al. Frontiers in Immunology
- CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function
- (2017) Arata Takeuchi et al. Frontiers in Immunology
- Characterization of age-associated exhausted CD8+T cells defined by increased expression of Tim-3 and PD-1
- (2016) Kyoo-A Lee et al. AGING CELL
- Defining secondary progressive multiple sclerosis
- (2016) Johannes Lorscheider et al. BRAIN
- Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
- (2016) Roland Martin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches
- (2015) V. V. Bashinskaya et al. HUMAN GENETICS
- T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate
- (2015) Laura K. Mackay et al. IMMUNITY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2015) F. H. Jacques et al. NEUROLOGY
- Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
- (2015) Ben J. E. Raveney et al. Nature Communications
- Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis
- (2014) Ilana Katz Sand et al. Multiple Sclerosis Journal
- Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial
- (2014) J. Romme Christensen et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis
- (2013) Diego Cadavid et al. PLoS One
- Nuclear Receptor NR4A2 Orchestrates Th17 Cell-Mediated Autoimmune Inflammation via IL-21 Signalling
- (2013) Ben J. E. Raveney et al. PLoS One
- Mechanisms regulating regional localization of inflammation during CNS autoimmunity
- (2012) Emily Pierson et al. IMMUNOLOGICAL REVIEWS
- The Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated from the Brain
- (2012) L. M. Wakim et al. JOURNAL OF IMMUNOLOGY
- Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel
- (2012) Tongguang Wang et al. PLoS One
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci
- (2011) Nikolaos A. Patsopoulos et al. ANNALS OF NEUROLOGY
- Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability
- (2011) Stefan D Roosendaal et al. Multiple Sclerosis Journal
- Evidence for a two-stage disability progression in multiple sclerosis
- (2010) E. Leray et al. BRAIN
- Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves
- (2010) Birgit Grund et al. Current Opinion in HIV and AIDS
- Impact of multiple sclerosis relapses on progression diminishes with time
- (2009) H. Tremlett et al. NEUROLOGY
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines
- (2008) Y. Doi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started